Evidence map›Paper›PMID 22952225›Full record

ArticleThe Journal of biological chemistry2012

Substrate recognition by the multifunctional cytochrome P450 MycG in mycinamicin hydroxylation and epoxidation reactions.

Shengying Li, Drew R Tietz, Florentine U Rutaganira, Petrea M Kells, Yojiro Anzai, Fumio Kato, Thomas C Pochapsky, David H Sherman, Larissa M Podust

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. High ResolutionFrontiers in molecular biosciences · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. (+)-Sesamin-oxidising CYP92B14 shapes specialised lignan metabolism in sesame.The Plant journal : for cell and molecular biology · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Shengying LiLife Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, USA.
Drew R Tietz
Florentine U Rutaganira
Petrea M Kells
Yojiro Anzai
Fumio Kato
Thomas C Pochapsky
David H Sherman
Larissa M Podust
Brandeis University · USToho University · JPUniversity of California, San Francisco · USCenter for Discovery · USChinese Academy of Sciences · CNUniversity of Michigan–Ann Arbor · US

Funding

XRAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS: PROTEIN SORTINGP41RR001081 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 1985 to 2011
$17.6M
RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
STRUCTURE AND DYNAMICS OF METAL-CONTAINING PROTEINSR01GM044191 · NIGMS · BRANDEIS UNIVERSITY · PI POCHAPSKY, THOMAS CHARLES · 1995 to 2012
$3.4M
Structure and Engineering of Natural Product Cytochrome P450 EnzymesR01GM078553 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTGOMERY, JOHN, PODUST, LARISSA M. · 2007 to 2015
$2.9M
An 800 MHz NMR spectrometer for the Boston areaS10RR017269 · NCRR · BRANDEIS UNIVERSITY · PI POCHAPSKY, THOMAS CHARLES · 2003 to 2003
$2.0M
STRUCTURE &DYNAMICS OF METAL-CONTAINING PROTEINS BY NMRR29GM044191 · NIGMS · BRANDEIS UNIVERSITY · PI POCHAPSKY, THOMAS CHARLES · 1990 to 1994
–
NCRR NIH HHS P41 RR001081NCRR NIH HHS S10 RR017269NIGMS NIH HHS GM44191NIGMS NIH HHS R01 GM044191NIGMS NIH HHS R01 GM078553NIGMS NIH HHS T32 GM064337
6 · The paper itself

Abstract

The majority of characterized cytochrome P450 enzymes in actinomycete secondary metabolic pathways are strictly substrate-, regio-, and stereo-specific. Examples of multifunctional biosynthetic cytochromes P450 with broader substrate and regio-specificity are growing in number and are of particular interest for biosynthetic and chemoenzymatic applications. MycG is among the first P450 monooxygenases characterized that catalyzes both hydroxylation and epoxidation reactions in the final biosynthetic steps, leading to oxidative tailoring of the 16-membered ring macrolide antibiotic mycinamicin II in the actinomycete Micromonospora griseorubida. The ordering of steps to complete the biosynthetic process involves a complex substrate recognition pattern by the enzyme and interplay between three tailoring modifications as follows: glycosylation, methylation, and oxidation. To understand the catalytic properties of MycG, we structurally characterized the ligand-free enzyme and its complexes with three native metabolites. These include substrates mycinamicin IV and V and their biosynthetic precursor mycinamicin III, which carries the monomethoxy sugar javose instead of the dimethoxylated sugar mycinose. The two methoxy groups of mycinose serve as sensors that mediate initial recognition to discriminate between closely related substrates in the post-polyketide oxidative tailoring of mycinamicin metabolites. Because x-ray structures alone did not explain the mechanisms of macrolide hydroxylation and epoxidation, paramagnetic NMR relaxation measurements were conducted. Molecular modeling based on these data indicates that in solution substrate may penetrate the active site sufficiently to place the abstracted hydrogen atom of mycinamicin IV within 6 Å of the heme iron and ~4 Å of the oxygen of iron-ligated water.

Indexed as

Bacterial ProteinsBinding SitesCrystallography, X-RayCytochrome P-450 Enzyme SystemEpoxy CompoundsGlycosylationHydroxylationMacrolidesMagnetic Resonance SpectroscopyMethylationMicromonosporaModels, MolecularMolecular StructureMutationOxidation-ReductionProtein BindingBacterial ProteinsCytochrome P-450 Enzyme SystemEpoxy CompoundsMacrolidesMycG protein, Micromonosporamycinamicins

Identifiers

PMID22952225
PMCPMC3488060
OpenAlexW2112271922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.